Stockscreener 앱 받기
20.37
0.69%
0.14
시간 외 거래:
20.30
-0.07
-0.34%
Anika Therapeutics Inc 주식(ANIK)의 최신 뉴스
Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Anika Therapeutics, Inc. (ANIK) Stock Price, News, Quote & History - Yahoo! Finance Canada
Anika Therapeutics, Inc. (ANIK) stock price, news, quote and history - Yahoo Finance Singapore
Anika Therapeutics assumed with a Buy at B. Riley - TipRanks
ANIK Assumed by B. Riley Securities -- Price Target Raised to $2 - GuruFocus
B.Riley assumes Anika Therapeutics stock coverage with buy rating - Investing.com
B. Riley Securities Initiates Anika Therapeutics(ANIK.US) With Buy Rating, Announces Target Price $23 - Moomoo
Anika Therapeutics (AKP) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug - TradingView
Technical Reactions to ANIK Trends in Macro Strategies - news.stocktradersdaily.com
Anika Therapeutics (ANIK) Retreats 1.06% as Shares Hold Above Key $19.56 SupportWave Extension - siam.in
Anika Therapeutics Inc. (ANIK) News, Articles, Events & Latest Updates - Stocktwits
Best Momentum Stocks to Buy for August 26th - Yahoo Finance
Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Anika Therapeutics Inc (NASDAQ: ANIK) Share Price, ANIK Stock News, ANIK Share Price & Updates - kalkine.ca
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why? - TradingView
Anika Therapeutics (NASDAQ:ANIK) Stock Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Anika Therapeutics (ANIK) Is Up 11.10% in One Week: What You Should Know - Yahoo Finance
Anika Therapeutics Inc (ANIK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zacks.com featured highlights include OptimumBank, EuroDry, Enova International, Anika Therapeutics and The GEO - Yahoo Finance
Understanding Momentum Shifts in (ANIK) - Stock Traders Daily
Anika Therapeutics Stock Price Forecast. Should You Buy ANIK? - StockInvest.us
ANIK (NASDAQ: ANIK) holder plans Form 144 sale of 16,864 shares - stocktitan.net
Anika (ANIK) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Anika Therapeutics (NASDAQ:ANIK) Raised to Strong-Buy at Zacks Research - MarketBeat
Anika Therapeutics (ANIK) Insider Gary Fischetti Buys 2,000 Shar - GuruFocus
Anika Therapeutics (NASDAQ:ANIK) Director Purchases 1,000 Shares - MarketBeat
Anika Therapeutics (ANIK) director purchases 2,000 common shares in market buys - Stock Titan
Anika Therapeutics (ANIK) Dips 2.14% to $19.19 as Support Level Comes into FocusModified Schiff - careplusvn.com
Anika Therapeutics Lifts Outlook After Margin Surge - TipRanks
Q1 2025 Anika Therapeutics Inc Earnings Call Transcript - GuruFocus
Anika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance - Yahoo Finance
Anika Therapeutics Gains 29%, Insider Trades Reap Benefit - Moomoo
Wall Street Zen Upgrades Anika Therapeutics (NASDAQ:ANIK) to Strong-Buy - MarketBeat
Anika Therapeutics Inc. Revenue Breakdown – NASDAQ:ANIK - TradingView
Anika Therapeutics expands Integrity implant reach with 3,300 U.S. procedures and international availability - Traders Union
Vanguard Capital Management (ANIK) discloses 4.95% beneficial stake in Anika Therapeutics - Stock Titan
B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating - Moomoo
B. Riley Securities Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Raises Target Price to $21 - Moomoo
These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months - stocktwits.com
Anika Therapeutics Q2 2026 slides: margins surge, guidance raised By Investing.com - Investing.com Nigeria
Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: - GuruFocus
Is Anika Therapeutics Inc (ANIK) On The Rise After Q2 Earnings B - GuruFocus
Anika Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Transcript : Anika Therapeutics, Inc., Q2 2026 Earnings Call, Jul 29, 2026 - marketscreener.com
Anika Therapeutics Q2 revenue rises 16% to $32.6 million - Quiver Quantitative
Anika: Q2 Earnings Snapshot - KING5.com
BRIEF-Anika Therapeutics Q2 Revenue USD 32.61 Million - TradingView
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook - TradingView
ANIK|Anika Therapeutics Inc|Price:15.010|Chg%:+0.060 - TradingKey
Anika Therapeutics Inc (ANIK) Balance Sheet - TradingKey
Anika Therapeutics Inc (ANIK) Income Statement - TradingKey
Anika Therapeutics Inc (ANIK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ANIK|Anika Therapeutics Inc|Price:15.030|Chg%:+0.010 - TradingKey
Anika Therapeutics Inc (ANIK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anika Therapeutics Inc (ANIK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Anika Therapeutics Inc (ANIK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anika Therapeutics Inc (ANIK) Cash Flow - TradingKey
Anika Therapeutics Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Anika Therapeutics, Inc. Revenue Breakdown – BX:AKP - TradingView
Anika Therapeutics Inc (ANIK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anika Therapeutics Q1 2026 Earnings: Strong EPS Beat Driven by Operational EfficienciesFree Cash Flow Trends - dars.gov.et
Anika Therapeutics (ANIK) 2026 CG Musculoskeletal Conference Summary - Quartr
Anika Therapeutics (ANIK) Proxy filing Summary - Quartr
Anika Therapeutics (ANIK) Q4 2025 earnings summary - Quartr
0.18%
0.69%
자본화:
|
볼륨(24시간):